APA (7th ed.) Citation

Kamiya, H., & Panlaqui, O. M. (2021). Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody. BMJ open, 11(3), e040465. https://doi.org/10.1136/bmjopen-2020-040465

Chicago Style (17th ed.) Citation

Kamiya, Hiroyuki, and Ogee Mer Panlaqui. "Systematic Review and Meta-analysis of the Risk of Rheumatoid Arthritis-associated Interstitial Lung Disease Related to Anti-cyclic Citrullinated Peptide (CCP) Antibody." BMJ Open 11, no. 3 (2021): e040465. https://doi.org/10.1136/bmjopen-2020-040465.

MLA (9th ed.) Citation

Kamiya, Hiroyuki, and Ogee Mer Panlaqui. "Systematic Review and Meta-analysis of the Risk of Rheumatoid Arthritis-associated Interstitial Lung Disease Related to Anti-cyclic Citrullinated Peptide (CCP) Antibody." BMJ Open, vol. 11, no. 3, 2021, p. e040465, https://doi.org/10.1136/bmjopen-2020-040465.